Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies

BACKGROUND: The COVID-19 pandemic has highlighted disparities in healthcare, particularly in the United States, even though disparities have existed since the organization of the modern healthcare system. Recruitment of patients from racial and ethnic minority groups is often minimal in phase 3 clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Craig, Timothy J., Zaragoza-Urdaz, Rafael H., Li, H. Henry, Yu, Ming, Ren, Hong, Juethner, Salomé, Anderson, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508782/
https://www.ncbi.nlm.nih.gov/pubmed/36153561
http://dx.doi.org/10.1186/s13223-022-00721-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508782/
https://www.ncbi.nlm.nih.gov/pubmed/36153561
http://dx.doi.org/10.1186/s13223-022-00721-y

Ejemplares similares